List of Topics | GSBG 2027

01 Topics

Every session topic at GSBG 2027.

A complete, searchable index of session topics across 35 scientific sessions. Use this page to plan your attendance or to find the right call for your abstract submission.

01 Track

Synthetic Biology & Biomanufacturing

Cell-free systems, metabolic engineering and industrial biotech.

Track details

Cell-free protein synthesis: Sutro XpressCF, Nuclera eProtein
AI-guided enzyme design: ESM3, ProGen, RFdiffusion for biocatalysts
Automated strain engineering foundries and DBTL cycles
Perfusion bioreactors and continuous biomanufacturing
Precision fermentation: recombinant proteins and cultivated meat
CHO and HEK293 cell line development for biologics
mRNA and AAV manufacturing scale-up and analytics

02 Track

Genetic Engineering & CRISPR

Base editing, prime editing, gene drives and delivery systems.

Track details

In vivo base editing: Verve VERVE-102, Beam BEAM-301 readouts
Prime editing: PASSIGE, twinPE, and Prime Medicine pipeline
CRISPR-Cas9 ex vivo: Casgevy clinical and manufacturing experience
LNP and engineered AAV capsid delivery for gene editing
Epigenetic editing: dCas9-DNMT3A/TET1 for durable silencing
Off-target detection: GUIDE-seq, CIRCLE-seq, ONE-seq
Gene drives and ecological containment strategies

03 Track

Tissue Engineering & Biomaterials

Scaffolds, 3D bioprinting and regenerative medicine.

Track details

Volumetric and DLP bioprinting for vascularized constructs
iPSC-derived organoids and assembloids for disease modeling
Bioengineered islets: Vertex VX-880, encapsulation strategies
Decellularized ECM scaffolds and recellularization
GelMA, alginate, and self-assembling peptide bioinks
Vascularization strategies: sacrificial templating, angiogenic factors
Bioprinted skin and cartilage: clinical translation pathways

04 Track

Medical Devices & Sensors

Implantables, point-of-care diagnostics and biosensors.

Track details

Brain-computer interfaces: Neuralink N1, Synchron Stentrode, Paradromics
Continuous glucose monitoring and multi-analyte wearable biosensors
CRISPR-based diagnostics: SHERLOCK, DETECTR for point-of-care
Ingestible electronic capsules and gut-targeted sensing
Bioelectronic medicine and closed-loop neuromodulation
Microfluidic lab-on-chip and droplet-based diagnostics
FDA SaMD pathways and AI/ML medical device regulation

05 Track

Bioinformatics & Computational Biology

Genomics pipelines, AI-driven drug discovery.

Track details

AlphaFold 3 and RFdiffusion for structure prediction and design
AI drug discovery: Isomorphic, Recursion, Insilico, Xaira
Single-cell and spatial transcriptomics: Visium HD, MERFISH, Stereo-seq
Genomic foundation models: Evo, Nucleotide Transformer, scGPT
Perturb-seq and CRISPR screen analysis at genome scale
Long-read sequencing: Oxford Nanopore, PacBio HiFi pipelines
Federated learning and privacy-preserving clinical genomics

06 Track

Drug Delivery Systems

Nanocarriers, controlled release, targeted therapeutics.

Track details

Lipid nanoparticles for mRNA and gene editing payloads
Antibody-drug conjugates: linker chemistry and bystander effects
Extra-hepatic targeting: SORT LNPs, GalNAc, peptide-conjugates
Engineered exosomes: Codiak, Evox therapeutic platforms
Focused-ultrasound BBB opening for CNS drug delivery
Oral biologics and intestinal permeation enhancers
Stimuli-responsive hydrogels and long-acting injectables

07 Track

Biomechanics & Prosthetics

Rehabilitation engineering, exoskeletons and smart prosthetics.

Track details

Osseointegrated prostheses and implanted myoelectric sensors
Targeted muscle and sensory reinnervation for sensory feedback
Self-balancing exoskeletons: Wandercraft Atalante, ReWalk, Ekso
Soft exosuits and wearable robotics for stroke rehabilitation
Microprocessor knees and AI gait-phase classification
OpenSim musculoskeletal modeling and inverse dynamics
Peripheral nerve interfaces: Utah arrays, regenerative electrodes

08 Track

Regulatory & Bioethics

FDA pathways, clinical trial design, responsible innovation.

Track details

FDA RMAT, accelerated approval, and platform technology designation
AI/ML SaMD: predetermined change control plans and GMLP
Germline editing governance and international heritable-edit policy
Bespoke and N-of-1 ASO and gene therapy regulatory pathways
Neural data privacy and BCI informed consent frameworks
Decentralized clinical trials and real-world evidence
Dual-use research of concern in synthetic biology

09 Track

Industrial Biotechnology

Enzyme engineering, bioprocessing and sustainable production.

Track details

PET-degrading enzymes: PETase, FAST-PETase, leaf-branch compost cutinase
Gas fermentation: LanzaTech, Kiverdi for CO and CO2 valorization
Engineered yeast for cannabinoids, opioids, and terpenoids
Directed evolution and ML-guided enzyme engineering
Continuous downstream processing and single-use bioreactors
Digital twins and process analytical technology (PAT)
Techno-economic analysis and scale-up from bench to commercial

Have research aligned to one of these topics?

Submit your abstract by December 20, 2026. Oral and poster presentations are welcome across all nine tracks.

Submit Abstract